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The objective of this study was to determine whether corneal stromal cells (CSC) from 
the limbal and central corneal stroma in dogs have multipotent mesenchymal stromal 
cell (MSC) properties, and whether this cell population can be differentiated into 
keratocyte‐like cells (KDC). Normal, donated, mesocephalic dog corneas were used to 
isolate CSC in vitro. Immunhistochemistry (IHC) demonstrated a distinct population of 
CD90 expressing cells in the anterior stroma throughout the limbal and central cornea. 
CSC could be cultured from both the limbal and central cornea and the culture kinetics 
showed a progenitor cell profile. The CSC expressed stem cell markers CD90, CD73, 
CD105, N‐cadherin and Pax6 whereas CD34 was negative. Limbal and central CSC 
differentiated into osteoblasts, chondrocytes and adipocytes confirming their 
multipotency. Co‐culturing allogeneic peripheral blood mononuclear  cells  (PBMCs) with 
limbal CSCs did not affect baseline PBMC proliferation  indicating  a  degree  of innate 
immune privilege. Limbal CSC could be differentiated into KDCs that expressed 
Keratocan, Lumican  and ALDH1A3,  and  downregulated Pax6  and  N‐cadherin. In 
conclusion canine corneal stromal cells have multipotent MSC properties similarly 
described in humans and could serve as a source of cells for cell therapy and studying 
corneal diseases. 







The cornea is an optically clear tissue permitting light transmission into the eye and is 
essential for the biodefense and refractive system of the eye [1]. The basic anatomical 
structure of the cornea between mammals is similar. It is composed of an anterior 
epithelium and its basement membrane, the stroma, the Descemet’s membrane, which is 
the basement membrane formed by the single layered posterior endothelium. However, a 
distinct layer comparable to the anterior limiting lamina (Bowman’s layer) that is present 
in the human cornea does not exist in dogs [2,3]. 
Dogs can suffer from inherited diseases affecting the cornea, such as corneal crystalline 
dystrophy and corneal fibrosis which remains one of the leading causes of blindness in 
animals and people worldwide [4,5]. Blindness has severe consequences for working dogs 
but also negatively affects the quality of life in pet dogs. In contrast to human 
ophthalmology, corneal transplantation is rarely performed in dogs. This is due to a shortage 
of donors, expensive storage costs, and the lack of a canine corneal tissue bank [6]. 
Funderburgh et al. (2005) described a population of  Pax6 expressing cells (<4%)  in the 
bovine corneal stroma and  identified  them  as progenitor cells. Stromal  cells expressing 
mesenchymal stem cell (MSC) markers in the anterior stroma close to  the  limbus  and central 
cornea, were also identified in humans [7]. A recent publication has also described a stromal 
stem cell population that originates from the human central corneal stroma [8]. Corneal 
stromal cells of the limbus in humans were found to fulfill the minimal criteria of The 
International Society for Cellular Therapy (ISCT) for multipotent MSCs [9‐11]. In vitro, human 
corneal stromal cells also referred to as corneal stromal stem cells (CSSC) were 
differentiated into keratocytes that expressed Lumican, Keratocan, and ALDH1A1 and lost 
expression of Pax6 and ABCG2 [12‐14]. A stable keratocyte phenotype has been described 
in relation to the differentiation process [15]. 
Similar to many other multipotent MSCs, CSSC are described to have immunomodulatory 
properties, which has relevance for preventing graft rejection for the purpose of tissue 
engineering. An in vivo study in mice has shown lack of tissue rejection after injecting CSSC 





in a corneal fibrosis model [16]. A study using a mixed lymphocyte reaction with limbal 
CSSC showed an inhibition of the proliferation of activated PBMCs [8]. 
To date, CSSCs are thought to primarily have asupport function for limbal epithelial stem 
cells (LESC)This is reinforced by the fact that basal epithelial cells in the limbal niche are in 
direct contact with stromal cells, both cells produce N‐cadherin, a cell‐cell junction protein 
and LESC co‐cultured with CSSC have higher expansion and clonogenicity rates 
[17,18].,However, they may also have a role in corneal tissue homeostasis as an ex vivo 
model culturing sheep corneas with seeded CSSC after a LASIK procedure (laser in situ 
keratomileusis) showed significantly increased adherence of LASIK‐like flaps while 
maintaining corneal transparency [8,19]. 
The current literature is based mainly on human, murine,rabbit and porcine corneal cells 
[20,21] but studies in canine corneas are not available This led to the aim of the study to 
locate and characterize corneal stromal cells in dogs and investigate whether they have 
multipotent MSC properties. This study will  provide  a  baseline  for  researchers  working with 
canine corneal disease models and for potential cell‐based therapy in veterinary 
ophthalmology. 
Materials and MethodsDonor material, selection and exclusion criteria 
 
Corneas were isolated from 14 healthy donor corneas of dogs euthanized for reason 
unrelated to this project and with the consent of the Animal Health Trust Ethical Review 
Committee (AHT_31_2013). Before excision of the cornealscleral buttons, the eyes were 
examined using a handheld slit lamp (KOWA SL14, Kowa Company LTD, Naka‐ku, Nagoya, 
Aichi, Japan) by a board‐certified veterinary ophthalmologist (CK). 
The mean ages (± SD, range) of corneal donors was 4.61 years (± 3.97; median: 2; range: 
0.2‐12 years). There were eight different mesocephalic breeds included, brachycephalic 
breeds were excluded. The gender distribution was composed of intact males (n= 6), intact 
female (n= 1), spayed females (n= 4) and neutered males (n= 3). Details about the donor 
tissues are listed in the Supplementary table 1. 





Cultured CSCs of each donor were expanded, cryopreserved and then randomly selected in 
the following experiments. For each experiment ≥3 independent biological replicates were 
used (i.e. cells derived from 3 or more different donor dogs). 
Cell isolation and cell culture 
 
Before excision, the eyes were examined using a handheld slit lamp (KOWA SL14, Kowa 
Company LTD, Naka‐ku, Nagoya, Aichi, Japan) by a board‐certified  veterinary ophthalmologist 
(CK). 
Within an average time of 8.28±3.38 h after confirmed death the cornealscleral buttons 
were excised. Left and right eyes were placed in separate containers containing Eagle’s 
Minimum Essential Medium (Sigma‐Aldrich, Gillingham, Dorset, UK), 5% dextran (Sigma‐ 
Aldrich), 2% foetal bovine serum (Gibco, Life Technologies, Paisley, UK) and 1% Antibiotic‐ 
Antimycotic mix (Sigma‐Aldrich) at room temperature for an average time of 13.5±6.38 
days (range: 6‐21days) with a weekly change of the media. 
The CSCs were isolated using a method similar to that described previously [12]. Briefly, 
with magnification  of 5.5x  surgical loupes  (Keeler, Winsdor, UK), the superficial  corneal 
limbal region was excised using a 300 µm set depth knife (BD, beaver visitec international, 
Bidford‐Upon‐Avon, Warwickshire, UK). The limbal anterior stroma including the epithelium 
was removed using corneal scissors and dissected into small fragments (3x3mm). The 
central cornea was trephined using a 7.5 mm corneal hand‐held trephine (Altomed, Bolden, 
UK) and dissected into strips using a 300 µm set depth knife. The limbal and central tissue 
fragments of each donor were processed separately and digested in 50% Dulbecco’s Modified 
Eagle’s Medium (DMEM) high glucose (Gibco), 50% DMEM/F12 (Gibco), supplemented with 
50 ug/mL gentamicin (Gibco), 1% Penicillin‐Streptomycin solution (Gibco), containing type 
L collagenase from Clostridium histolyticum (0.5 mg/mL; Sigma‐Aldrich) and incubated at 
37°C, 5% C02 for 12‐14 h. Selective trypsinization was used (TripLE express; Gibco) to 
separate the small oval shaped CSC from epithelial cells, keratocytes and melanocytes. CSCs 
were expanded to a maximum confluency of 60‐70%. The medium was changed every 48‐
72 hours. CSC medium was composed of DMEM low glucose  (Gibco)  and  MCDB‐201  
(Sigma‐Aldrich)  medium,  10  ng/mL  epidermal  growth 





factor (EGF) (Sigma‐Aldrich), 10 ng/mL platelet‐derived growth factor (PDGF‐BB; R&D 
Systems, Abingdon, Oxford, UK), Insulin‐Transferrin‐Selenium (Gibco), 0.1 mM ascorbic acid‐
2‐phosphate (Sigma‐Aldrich), 10‐8 M dexamethasone (Sigma‐Aldrich), 1% Penicillin‐ 
Streptomycin (Gibco), 50 ug/mL gentamicin (Gibco), 100 ng/mL cholera toxin (Sigma‐ 
Aldrich), supplemented with 2% fetal bovine serum (FBS) (Invitrogen, Thermo‐Fisher 
Scientific, Paisley, UK) [15]. 
Population doubling time and population doublings 
 
The mean population doubling time (PDT) was calculated from three biological independent 
limbal and central derived CSC lines (8 year old Springer Spaniel (No. 10), 12 year old Lurcher 
(No.11), 12 year old Golden Retriever  (No.  12),  Supplementary  table 1).The doubling time 
and number of cell doublings was calculated at each passage until the stationary phase was 
reached (P1‐P6). (Roth V. 2006 Doubling Time Computing, Available from:  
http://www.doubling‐time.com/compute.php) 
The population doubling of cells was calculated as: 
Number of Cell Doublings (NCD) = log10(y/x)/log102, where “y” is the final density and ‘x’ is 
the initial seeding density of the cells [10]. 
The cell number of P0‐P1 was not included as CSC derived from cultured limbal and central 
cells had epithelial cell contamination. 
Keratocyte differentiation of CSCs 
 
Limbal and central derived CSCs (passage 2‐5) of a 12 year old Lurcher, (No.11), 12 year old 
Golden Retriever (No. 12), and a 2 year old Border Collie (13) (see Supplementary table 1) 
were cultured in keratocyte differentiation medium (KDM) consisting of advanced DMEM 
(Sigma‐Aldrich), 10 ng/mL human basic fibroblast growth factor (bFGF) (Sigma‐Aldrich), 0.1 
mM L‐ascorbic acid‐2‐phosphate (Sigma‐Aldrich), 50 ug/mL gentamicin (Invitrogen), 1% 
Penicillin‐Streptomycin (Gibco), 1% Gluta‐MAX (Gibco). Medium was changed  every  2‐3 days. 
Cells of each donor and location (limbal/central) were cultured separately. A seeding density 
of 1x10³ cells/cm² and one passage between 10‐14 days was necessary to maintain stellate 
cell morphology, avoid cell confluency and cell sheet formation. A second culture experiment 
was conducted with the same media but lacking human bFGF (Sigma‐Aldrich). 





Cell culture of adipose‐derived mesenchymal stem cells 
 
Three lines of canine adipose‐derived MSCs (adMSC) that  had  been  derived  previously were 
used as positive controls (11 year old Mix breed (No. 15) ,8 year old Irish setter (No. 16), 6 
weeks old Dalmatian (No. 17) (see Supplementary table 1)) [22]. The cryopreserved MSCs 
were thawed into DMEM (Gibco) with 10% FBS (Gibco), 1% Penicillin‐Streptomycin (Gibco) 
and 2 mM L‐glutamine (Gibco). Media was replaced every 2‐3 days. MSCs were used 
between passages 2‐5. 
Histology, Immunohistochemistry and Immunofluorescence staining 
 
Three corneas from biological independent donors (1.2 year old (no.1), 1.3 year old (no.2) 
and 1.5 year old (No.3) Staffordshire bull terrier, see Supplementary table 1) were 
embedded in O.C.T. tissue compound (Tissue Tek®, VWR, Lutterworth, Leicestershire, UK). 
The tissue was separated in the dorsal, temporal, ventral and nasal regions, snap frozen in 
liquid nitrogen and cut in 7 μm thick frozen sections for routine automated Haematoxylin‐ 
Eosin and Periodic Acid Schiff (PAS) staining. Immunohistological investigations were 
performed on each of the four indicated regions. 
The sections were fixed in 3% paraformaldehyde for 20 min., washed in PBS and 
permeabilized in 0.1% Triton‐X100 (Sigma Aldrich) in PBS for 20min. 
Limbal and central CSCs, their differentiated keratocyte‐like cells (KDCs) from three 
different donors (12 year old Lurcher (No.11), 12 year old Golden retriever (No. 12), 2 year 
old Border collie (No. 13), see Supplementary table 1,) and adMSCs were plated onto 
Fibronectin (FNC coating mix, Athena Enzyme systemsTM, Baltimore,  USA)  coated permanox 
slides at a density of 4x104 cells/slide, cultured for a 2‐3 days in CSC, MSC (at 
passage 2–5) or keratocyte differentiation media (KDM), fixed with 3% paraformaldehyde 
for 20 minutes. For sections and fixed cells prepared for identification of keratocyte markers, 
0.1% Tween 20 (Sigma‐Aldrich) in PBS was used for washing procedures. Cells/sections 
were blocked with 10% goat/donkey serum (Sigma‐Aldrich) in PBS for 60 minutes at 
room temperature (RT). Details of primary and secondary antibodies are summarized in 
supplementary table 2. Briefly, the cells/sections were incubated with the primary antibody 
in 5% blocking serum (goat or donkey serum (both Sigma‐Aldrich) in PBS 





at 4°C overnight. Slides were washed in PBS and incubated with corresponding secondary 
antibody diluted in 5% blocking serum in PBS for 1 hour at RT and FITC‐labelled phalloidin 
(1:1000 concentration; Sigma‐Aldrich), which binds to the actin cytoskeleton, mounted in 
Vectashield with the nuclear stain DAPI (Vector laboratories Inc., Peterborough, UK) and 
evaluated with a confocal microscope (Zeiss LSM 700, Cambridge, UK). Rabbit and Mouse 
IgG isotype controls were performed. 
Flow Cytometry 
 
Flow cytometry was performed on three independent biological replicates of limbal CSCs 
(12 year old Lurcher (No.11), 12 year old Golden retriever (No. 12), 2 year old Border collie 
(No. 13) Supplementary table 1,). Cells were fixed in 3% paraformaldehyde (Sigma‐Aldrich) 
for 20 minutes prior to washing, permeabilized in 0.1% Triton x‐100 for 1 h (except for 
CD90) and blocked in 10% goat or donkey serum (Sigma‐Aldrich) for 30 min. Cells (1 x106) 
were incubated for 45 min at 4°C with primary antibody, rabbit or sheep IgG, followed by 
incubation with the appropriate FITC labeled secondary antibody for 45min 4°C. Details of 
all primary and secondary antibodies used for immunostaining are listed in supplementary 
table 2. 
A FACS Calibur flow cytometer (BD Biosciences Immunocytometry Systems, Franklin Lakes, 
NJ) was used and the data were analyzed  using  Novoexpress  ®  Software  (ACEA Biosciences, 
San Diego, USA). Events were gated to exclude dead cells and cell debris by forward versus 
side scatter height (R1). R1 events were gated to remove doublets (R2) by forward scatter 
height versus forward scatter area. 2% of events in the R2 isotype control and everything 
to the right were included in a new gate (R3) by FITC height versus forward scatter height 
[23]. The overlaid events of each primary antibody gated within R3 were considered 
positive. The events were expressed as means of positive cells (%). 
RNA extraction and Quantitative Reverse Transcriptase Polymerase Chain Reaction 
 
Total RNA was extracted from corneal tissue, 1×106 limbal CSC (passage 4‐5) and 1×106 of 
their KDC of three different donors (12 year old Lurcher (No.11), 12 year  old  Golden retriever 
(No. 12), 2 year old Border collie (No. 13), see Supplementary table 1,) using Tri‐ reagent  
(Sigma‐Aldrich), purified  using  the  RNeasy  mini  kit  (Qiagen,  Germantown,  USA) 





and treated with Ambion DNA‐free (Life Technologies) to remove genomic DNA. cDNA was 
made from 1 μg of RNA using the sensiFAST  cDNA  synthesis kit (Bioline, London,  UK). Aliquots 
of 2 μl cDNA were used in qPCR, which was carried out using SYBR Green containing 
supermix (Bioline) on the Bio‐Rad C1000 Touch Thermal Cycler (Bio‐Rad, Watford, UK). 
QPCR reactions were performed in duplicate. The cycle parameters were 95°C for 10 min, 
followed by 40 cycles of 95°C for 15 s, 60°C for 15 s and 72°C for 15 s. Finally, a melt 
curve was produced by taking readings every 1°C from 65°C to 95°C. The levels of canine 
18S rRNA did not change between treatments (data not shown) and it was used to normalize 
gene expression using the 2−ΔΔCt method [24]. 
Primers were designed from annotated canine exon sequence for the genes of interest 
using primer3 (https://primer3.org/webinterface.html) and mfold 
(http://unafold.rna.albany.edu/?q=mfold) software to obtain amplicons with a melting 
temperature (Tm) of 58°C – 62°C, devoid a secondary structure at Tm 60°C and with an 
amplicon size of 50‐150 bp. Primers were produced by Sigma‐Aldrich. Primer sequences 
can be found in the Supplementary table 3. 
Assays for Adipogenesis, Osteogenesis and Chondrogenesis 
 
Central (donor: 6 weeks old Dalmatian (No. 8), 8 weeks old Old english sheepdog (No. 9), 
12 year old Golden Retriever (No. 12), 2 year old Border Collie (No. 13) and limbal (donor: 
1 year old Staffordshire cross breed (No. 6), 8 week old Old english sheepdog (No. 9), 12 
year old Lurcher (No. 11), 2 year old Border Collie (No. 13) derived CSC and adMSC from 
three different donors of passage 2‐5 (see Supplementary table 1) were differentiated into 
adipocytes, chondrocytes and osteoblasts. The following modified protocols by Guest et al. 
2008 were used [25].For adipogenic differentiation CSC and adMSC were treated with 
antibiotic‐free fat induction media (DMEM supplemented with 10% foetal calf serum, 15% 
rabbit serum (Invitrogen), 10 μg/ml insulin, 1 μM dexamethasone, 0.02 mM indomethacin, 
and 0.5 mM 3‐isobutyl‐1‐methylxanthine (Sigma‐Aldrich) for 72 hours and followed by 
antibiotic‐free fat maintenance media (DMEM  supplemented  with  10%  fetal  calf  serum and 
10 μg/ml  insulin) for  72  h for three  alternating  cycles. Oil red  O staining  for lipid droplets 
was then carried out. 





For chondrogenic differentiation cells were treated with cartilage induction media (DMEM 
supplemented with 10% foetal calf  serum, 2 mM  L‐glutamine, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 1×10−7 M dexamethasone (Sigma) and 15 ng/ml TGF‐β1 (Peprotech, 
London,UK) for 21 days. Alcian blue staining (pH 1.0) was carried out overnight and short 
nuclei counterstain in 0.5% aqueous neutral red (30 sec) was performed. This was 
performed in 2D (biological triplicate) and 3D (biological singlicate) pellet form using a starting 
density of 1x 106 cells. The pellet was embedded in Tissue Tek® O.C.T. compound and 10µm 
frozen sections stained accordingly. 
For osteogenic differentiation cells were cultured for 21 days  in  osteogenic  induction media 
(DMEM supplemented with 10% foetal calf serum, 2 mM L‐glutamine, 100 U/ml penicillin, 
100 μg/ml streptomycin, 10 mM β‐glycerophosphate (Sigma), 10 nM dexamethasone and 
0.1 mM ascorbic acid (Sigma) before staining with von Kossa (Abcam, Cambridge, UK),Alizarin  
red S  (Sigma) and inorganic hydroxyapatite stain (OsteoImage™ Mineralization Assay, 
Lonza®, Walkersville, USA) according to the manufacturer’s instructions. The human sarcoma 
osteogenic cell line (SAOS‐2) served as positive control. 
Western Blot analysis 
 
Antibodies without canine specific references were tested  for  cross‐reactivity  and specificity 
to dog proteins using western blot. Details are in supplementary table 2. 
Protein was  extracted  from  whole cell extracts (WCEs) from  adMSC  (P4), CSC  (P4) and 
corneal tissues using 500 μl WCE buffer (5 mM EDTA, 5 M NaCl, 0.5 M Hepes pH7.9, 100 
mM PMSF), followed by three freeze and thaw cycles. Supernatants were collected by 
centrifugation at 4°C and stored at ‐20°C. 
To test the keratocyte markers Lumican and Keratocan, a deglycosylation step was 
performed using a combination of endo‐β Galactosidase (Sigma‐Aldrich) (0.57 Units/mg 
protein for 4 h at 37°C) and Chondroitinase ABC (Sigma‐Aldrich) (0.6 Units/mg protein) for 
4 h at 37°C) on 100 µg of corneal protein. 20 μg of denatured protein was run either on a 
10% or 5% SDS‐polyacrylamide gel and transferred to a PDVF  membrane. Immunoreactivity   
was   detected   using   the   ECL   plus   detection   system   (Amersham, 





Buckinghamshire, UK). Mouse anti‐β actin antibody (Abcam) was used as a positive control. 
PBMC media and isolation from lymph nodes 
 
The rapid destruction of peripheral blood PBMCs  through  the  use  of  commercial euthanasia 
agents prevented  the isolation  of PBMCs from  the  blood  of  the euthanized patients from 
the corneal donor study population. 
Therefore, the popliteii lymph nodes of two donor dogs were harvested 2 hours after 
euthanasia and transported on ice in PBMC media as described by Dutton et al 2018 [26]. 
PBMC media was composed of RPMI 1630, 10% heat inactivated FBS, 1% Penicillin‐ 
Streptomycin (Gibco), 2 mM L‐glutamine and 55 µM 2‐ßmercaptoethanol (all Sigma‐ 
Aldrich). 
Briefly, lymph nodes were excised, cut into small pieces  and  passed  through  a  70  µm sterile 
cell strainer (Sigma‐Aldrich) followed by several washes. The cell suspension was 
centrifuged at 300 G for 15 minutes and cells  were  frozen  in  liquid  nitrogen  a concentration 
of 4x106/ml in 90% PBMC media and 10% DMSO. After thawing 77‐95% of PBMCs were 
viable. 
 




CSCs were growth arrested with 15 µg/ml (2 hour incubation) Mitomycin C (MMC) (Sigma‐ 
Aldrich). PBMC co‐cultures were performed by incubating growth arrested, allogeneic CSC 
on a 96 well plate with effector PBMCs of two different donors in a ratio of 1:5 (CSC: 
PBMC). The experiment was performed on three  biologically  independent  limbal  CSCs from 
three different donors (donor: 1.3 year old Staffordshire bull terrier (No 2), 1.5 year old 
Staffordshire bull terrier (No. 3), 12 year old Golden retriever (No.12), see Supplementary 
table 1), (i.e. CSCs of three different donors were used with two different PBMC donors)). 
For the negative controls, PBMCs were MMC treated for 30 minutes at a 





concentration of 50 µg/ml before being washed and cultured with autologous effector PBMCs. 
For positive controls, growth arrested PBMCs were cultured with allogeneic effector PBMCs. 
Additionally, PBMCs were activated with 10 µg/ml Phytohemagglutinin (PHA, Sigma‐Aldrich). 
After 4 days the PBMCs were incubated with radioactive thymidine ([3H] thymidine) (GE 
Healthcare Bio‐sciences) at a final concentration of 0.5 µCi per well, at 37ºC, 5% CO2 for 
16‐18 hours before being frozen at ‐20ºC. Following thawing, cells were harvested using a 




Statistical analyses of the cell culture kinetics and gene expression data followed a normal 
distribution calculated by Shapiro‐Wilk normality test (W ) and p values >0.05 (XLSTAT‐ 
base, Witzenhausen, Germany). Group differences were calculated using an unpaired 
Student’s t‐test and p<0.05 was considered to be statistically significant. 
Results 
 
The canine limbus has epithelial invagination and an undulating basement membrane. A 
distinct population of corneal stromal cells in the limbus and central stroma express the 
mesenchymal stem cell marker CD90. 
By histology, limbal crypts and palisades of Vogt (as in humans) were absent in canines 
(Fig.1B), however a slight invagination of the epithelium in the stroma was noted. In the 
canine corneal limbus, the basement membrane was undulated and irregularly formed. 
There was no  evidence of  regional differences  (dorsal, ventral, nasal, temporal).  In the 
limbus, the basal cell layer of the epithelium was cell rich with more elongated basal cell 
nuclei similar to limbal epithelial stem cells (LESC). The corneal stromal cells were in direct 
contact or in close proximity to the irregular formed basement membrane (Fig.  1B).  A distinct, 
small population of these stromal cells expressed CD90 and extended into the mid‐
stroma of the limbal region in all four quadrants (Fig. 1B). 





In the central cornea, the basal cells of the epithelium were cuboidal in shape. The fine 
basement membrane was regularly formed and the stromal cells were separated from the 
basement membrane by a layer of corneal stroma (Fig.1C). A distinct population of stromal 
cells expressing CD90 extended into the mid‐stroma (Fig. 1C). Pax6 expressing stromal cells 
were not evident in the limbal or the central cornea. 
 
CSCs can be cultured in vitro from both the limbal and central cornea but have a limited 
self‐renewal 
 
Adherent cells were visualised approximately six hours post seeding. The cells adopted an 
ovoid morphology after 24 h but after the first passage, they showed a more spindle cell 
morphology and formed a syncytium of spindle cells with increasing confluency (Fig.2 Ai‐ 
iii). 
The  average  maximum  passage  was  9  (±2.94)  and  8  (±1.64)  (P=  0.55)  passages  over  a 
culture time of 23.5 (±3.31) and 19.6 (±4.33) days (P= 0.18) in limbal and central derived 
CSCs respectively (Fig. 2B). There were no statistically significant differences in cell numbers 
of the limbal and central CSCs over 6 passages (P= 0.54 (P1), P= 0.67 (P2), P=0.83 (P3), P=0.12 
(P4), P= 0.49 (P5),P= 0.44 (P6)) (Fig. 2C). The mean population doubling times between limbal 
and central derived CSC showed a trend that central CSC reached the stationary phase at an 
earlier passage (P3‐4) than the limbal CSC, but the difference did not reach statistical 
significance (P= 0.068) (Fig. 2D). In the early log‐phase, between P1‐2, a PDT of 25.02h and 
21.67h of limbal and central derived CSCs respectively were noted, which increased 
exponentially and reached the  stationary phase after five passages  for both central and 
limbal CSCs (Fig. 2D). The accumulative number of cell doublings between P1‐P5 was 12.84 
and 11.15 in limbal and central CSCs respectively (Fig. 2E). 
Canine CSCs have mesenchymal stromal cell characteristics 
 
Cultured limbal and central derived CSCs both expressed MSC markers. CSC showed strong 
expression of CD90 and CD73, whereas CD105 was less intensely expressed (Fig. 3). The 
nuclear paired box protein Pax6 (oculorhombin) and the intercellular membrane marker N‐ 
cadherin were expressed (Fig. 3). CD34, a haematopoietic stem cell marker and  alpha smooth 
muscle actin (α‐SMA), a myofibroblast marker were absent (Fig.3). 





Canine adMSCs were used as a positive control and showed a similar marker expression to 
CSCs but lacked expression of Pax6 and CD34 and had strong expression of α‐SMA (Fig. 3). 
Flow cytometry revealed that 83% of CSCs expressed Pax6, 96% expressed CD90 and CD73 
whereas 1% expressed CD34 (Fig. 4). 
Western blot analysis confirmed the specificity and cross reactivity of the antibodies to the 
dog proteins for Pax6, N‐cadherin, CD90, CD73 (supplementary figure 1). 
Furthermore, CSCs could differentiate into bone, fat and cartilage producing cells 
demonstrating their multipotency (Fig 5). Whilst there were no apparent differences in the 
high efficiency of CSC and MSC differentiation into adipocytes (Fig. 5 A vii,viii), the bone 
differentiation showed a moderate osteogenic response in both, CSCs and adMSCs (Fig. 5 
A i‐vi) (compare to Supplementary figure 2). CSC differentiation into cartilage 3D (Fig. 5 B i‐ 
iv) and 2D (Fig. 5 B v,vi)required a higher concentration of TGFβ1 than that used for MSC 
differentiation (15 ng/ml versus 10 ng/ml). 
CSCs are immune privileged in vitro 
 
Allogeneic limbal CSC co‐cultured with effector PBMCs did not modify the baseline level 
PBMC proliferation. In comparison co‐cultures of effector PBMCs with allogeneic PBMCs 
showed a significant (P< 0.001) increase in proliferation compared to non‐activated PBMC 
(Fig. 6). 
CSC differentiate into keratocyte‐like cells and bFGF plays an essential role in the down 
regulation of α‐SMA 
Limbal and central derived CSCs were cultured under low glucose, serum‐free conditions 
with substituted ascorbic acid to induce their differentiation into keratocytes (KDM). The 
small, polygonal morphology characteristic of CSCs changed to a  stellate  morphology typical 
of keratocytes within 7‐10 days (Fig. 7 A). A seeding number of 1x10³ cells/cm² 
differentiated in KDM containing human bFGF with an additional passage step maintained 
keratocyte marker expression without the expression of α‐SMA over 21 days. Keratocyte‐ 
like cells showed increased protein expression of Lumican, Keratocan and ALDH1A3, 
whereas Pax6 expression decreased and N‐cadherin expression became undetectable 
following differentiation (Fig. 7 B). This was reflected in the fold change in gene expression 





of KDCs to undifferentiated CSCs where Keratocan was significantly upregulated (P< 0.05)). 
Lumican (P=0.27) and ALDH1A3 (P=0.21) were also upregulated following differentiation 
but did not reach significance. In contrast the stem cell associated genes, Pax6 (P=0.077) 
was downregulated and N‐cadherin (P< 0.0001) was significantly downregulated (Fig. 8 A). 
Α‐SMA is a myofibroblastic marker, which is minimally expressed at the gene level and not 
detected at the protein level in undifferentiated CSCs (Fig. Fig. 8 B i, C) or following keratocyte 
differentiation in the presence of bFGF (Fig. 8 Bii, C). However, in the absence of bFGF, α‐
SMA gene is significantly upregulated (P< 0.001) and protein expression are detected in 
the differentiated cells (Fig. 8 B iii, C). 
Western blot analysis confirmed the specificity and cross reactivity of the antibodies to the 
dog proteins for Lumican, Keratocan and ALDH1A3 (Supplementary Fig.1). 
Discussion 
 
The corneal limbus in humans is located in the junction between the cornea and the sclera. 
In humans, the limbus is composed of limbal crypts and Palisades of Vogt which serves as a 
stem cell niche, for limbal epithelial stem cells (LESCs), which are responsible for self‐ renewing 
and repair of damaged corneal epithelium [27]. The loss  of  LESCs  results  in Limbal Stem 
Cell Deficiency (LSCD), and leads to inflammation, scarring, neovascularisation and possible 
blindness [28]. The fate of LESCs within their niche is  influenced  by  the stromal 
microenvironment. In humans, limbal stromal cells have MSC characteristics and are 
described as corneal stromal stem cells (CSSC) [29,30] or limbal MSCs (L‐MSC) [9,10]. In 
humans, these stromal cells are hypothesized to assist in the maintenance of the LESC 
niche [31]. 
This is the first description of limbal and central derived corneal stromal cells with 
multipotent MSC characteristics in dogs, similar to those described in humans 
[7,8,12,20,32]. We also provide essential baseline data of the limbal anatomy in dogs. 
A major anatomical difference to humans was the absence of limbal crypts and palisades 
of Vogt [33]. We can also confirm a slight invagination of the epithelium in the stroma as 
described by Patruno et al 2017 [33]. Well‐defined palisades of Vogt are present in the pig 
eye but reportedly absent in rabbits and rodents [34,35]. 





Immunohistologically, a small population of CD90 expressing stromal cells  in the limbal 
and central anterior corneal stroma was present. CD90 is a well‐accepted MSC marker, 
however, it can also be expressed by fibroblasts [11]. To characterise the CD90+ cell 
population in more detail, double or even triple IHC using  CD90,  α‐SMA  and  Vimentin should 
be included in future studies. Canine MSCs are characterized in the veterinary field, including 
adipose derived, bone marrow derived MSC’s and other tissue sources as amniotic‐derived, 
synovial –derived, periosteum [36‐42]. The international society for cellular therapy (ISCT) 
has defined a set of criteria that must be established to be characterized as a multipotent 
mesenchymal stromal cell [11]. Canine MSCs studies fulfilled these criteria, however positive 
and negative MSC marker profiles differ in various studies, some studies also demonstrated 
cells were  positive  for  the  pluripotency‐ associated genes NANOG, OCT4, and SOX2 [41,43]. 
Canine MSCs are not a homogenous cell population. Hence, proliferation capacity has been 
reported to be lower in  bone marrow (BM)‐MSCs in contrast to adMSCs and synovial MSCs 
[37,41]. Proliferation is also lower in MSCs isolated from older donors, “stemness” can 
decrease with passage frequency and the harvest site can have significant impact [43,44]. 
Breed related differences have also been described. For example BM‐MSCS of Howavart’s  
had significantly less colony forming units (CFU) than German Shepherd, Flat coated 
Retriever or Golden Retriever [45]. Therefore had human MSCs culture protocols adjusted 
to canine MSCs [42,46,47]. 
This is the first report of canine MS‐like cells of corneal origin and therefore the results are 
primarily compared to human corneal stromal MSC studies. The CSCs are isolated and cultured 
using different culture conditions to MSCs and therefore more detailed comparisons to 
canine MSCs in terms of culture conditions, cell proliferation, marker expression and 
differentiation potential may be beneficial in future work. 
Funderburgh et al 2005 described a small population of limbal stromal cells expressing the 
transcription factor Pax6 (oculorhombin) in bovine  corneas  [7].  This  could  not  be confirmed 
histologically in canine corneas [8]. 
Stromal cells from the canine limbal and central cornea  were successfully isolated and 
cultured.  Differential  trypsinisation  of  small  polygonal  cells,  which  reached  a  maximal 





confluency of 60‐70%, allowed the selective culture of CSC. A stem cell like appearance 
could largely be maintained throughout several passages [15]. CFU‐f assay of limbal and 
central CSCs as shown human limbal CSSC was not performed but should be included in 
future studies [9,10,48]. In contrast to Du et al 2005, selective cell sorting to expand a CSSC 
“side population” was not performed [12]. This approach in human cells, which used the 
same low serum CSSC culture media than in the present study, resulted in a population 
with a replicative lifespan typical of stem cells (18 passages and a cumulative population 
doubling of 80 until senescence was reached) [12].Human CSC populations cultured in 10% 
containing FBS without growth factor (EGF, PDGF), isolated without cell sorting produced 
more limited replication with 22.9 cell doublings between passages 2‐6 (higher than in 
dogs). However, a PDT of 29.1h and 34.1h similar to human MSC was observed only at 
early passages, similar to the present study [10]. 
Canine CSC underwent 12 and 11 population doublings for the limbal and central derived 
CSC respectively over 5 passages until  senescence  was  reached.  A  population  doubling time 
of approximately 24‐30h as described in canine MSCs was only reached in the early log‐
phase (P1‐P2) [36]. Guercio et al 2013 also reports a limited life‐span and senescence after 
passage 6 in canine adMSC (cultured in DMEM low glucose, 20% FBS) and revealed similar 
accumulated PD (11‐12) in a similar time (27‐28 d) to the present study of CSC. Bearden 
and colleagues 2017 showed that adipose and synovium canine MSCs proliferated first more  
rapidly with a rapid decline after passage 3, than marrow cMSCs, which we could very 
similar observed in CSC. However, we hypothesis that the limited self‐renewal of CSC 
population in dogs may suggest they are proliferating progenitor cells rather than stem 
cells or might resemble a mixed population of cells [49]. Hence, the term canine CSC was 
used instead of CSSC as in humans. The corneal stem cell media could also influence the 
degree of self renewal and might require optimization to the canine species in future 
studies. CSSC media contains only low serum levels of 2% FBS and not 10% or higher as in 
most canine MSC culture conditions . This was performed as higher serum concentrations 
have been shown to induce a myofibroblastic cell fate in rabbit keratocytes [50].Serum 
supplementation (10% v/v) led to human keratocyte differentiation into fibroblasts with 
loss of keratocan expression in human CSSC [12‐14]. Whether this holds true for canine 
keratocytes and canine CSC is unknown. The CSSC media also contains the growth factors 





EGF and plateled derived growth factor (PDGF)  It is described that factors as FGF, TGF‐ß, 
PDGF, insulin‐like growth factor 1 (IGF‐1) and EGF regulate keratocyte differentiation, 
migration and expression and are known to be essential growth factors in corneal in vitro 
studies [51,52]. A canine study of BM‐MSCs reported that cells expanded best in a‐MEM 
supplemented with bFGF [45] and future studies to optimise canine CSC media to maximise 
self‐renewal and differentiation potential are required. 
No significant differences in culture kinetics were observed between limbal and central 
derived CSCs, although the central CSC showed a trend towards lower frequency of passage, 
lower  cell numbers and earlier senescence. There was  a high degree of heterogeneity in 
cell expansion which might be explained by the wide age range of donor tissue (0.2‐12 
years) that was usedin this study, Comparative studies of the influence of age on human 
CSSCs which are isolated and cultured similar to canine CSC in the present study are lacking. 
However, donor age can negatively impact human and canine MSC cell expansion and 
differentiation [44,53]. 
Effects of age in skeletally immature (mean age: 4.9 ± 1.9 months) and mature (mean age: 
89.5 ± 20.9 months) dogs on canine BM‐MSCs were studied by Volk and colleagues 2012. 
BM cells were isolated from long bones (humeri, femurs, and tibias) and cultured in high 
glucose DMEM substituted with 10% FBS, showed a significant negative effect of age on 
both MSC frequency and the ability to differentiate along the osteogenic lineage  [44]. Guerico 
et al (2013) compared the age (young dogs: 1–4 years; adult dogs: 8–14 years) and the harvest 
site (subcutaneous versus visceral) of adMSCs cultured in low glucose DMEM and 20% FBS. 
Population doubling values at passages >2 were significantly higher for MSCs derived from 
subcutaneous fat and in younger dogs. CFU‐f assay in low glucose DMEM and 5% FBS did not 
differ according to age and harvest location site, but declined after passage 
> 2. 
 
The influence of donor age on cell expansion and differentiation of canine CSCs warrants 
further investigation in future studies. 
We were able to differentiate both limbal, central derived CSC and adMSC  into chondrogenic, 
adipogenic and ostegeogenic cellsin vitro. However, It should be noted that canine 
chondrogenesis in MSC has not been robustly demonstrated in the literature and 





difficulties in establishing a protocol are described [37,42]. In order to successfully drive 
chondrogenic differentiation  of the  CSCs, we had  to  use an  increased concentration  of 
TGF‐β1 compared to the MSCs. However, further optimization of the differentiation protocol 
could be performed [41] or a standardized commercial available differentiation media 
could be tested in future studies [43]. The induction of the osteoblastic lineage was 
demonstrated using a combination of van Kossa (mineralization –phosphate) and Alizarin S 
red (calcium) and hydroxyapatite staining but differentiation was not as robust when 
compared to SAOS‐2 cells (see Supplementary  figure  2).  Passage  number,  pluripotency gene 
expression [43] and donor age have all been shown to affect the differentiation capacity 
of canine MSCs and were not tightly controlled in the present study (cells were at passage 
2‐5 and from donors aged 0.2‐12 years). Future work could also optimise the osteogenic 
differentiation protocol, for example thorough the addition of BMP‐2 or IGF‐1 [41,47,54]. 
The immunophenotyping of limbal and central derived CSC showed remarkable similarity 
with the surface antigen profile of adMSC for CD90, CD73, CD105, N‐cadherin and CD34. In 
contrast to most human studies characterizing limbal CSCs, the present study  used  a limited 
number of protein markers; however, this reflects the nature of establishing protocols for 
the use of markers on canine tissue and cells. Most of the markers are not established in 
this species and therefore, western blot analysis had to confirm the specific binding. 
The expression of CD34 in human CSSCs and keratocytes is controversial in human corneal 
research. CD34 is a hematopoietic stem cell surface marker, which is defined to be absent 
(<2%) in MSCs [11]. This was also confirmed for human limbal and central CSSCs [8,10]. 
CD34 has been described as a characteristic marker of quiescent keratocytes in the human 
cornea [56]. Another study characterizing limbal MSCs showed a drop of CD34 marker 
expression with increasing cell proliferation and a shift to more progenitor cell type. This 
seems to be influenced significantly by the composition of culture media [9,57,58]. In our 
study we found CD34 protein expression in less than 2% of canine CSCs. Canine adMSC in 
the present study also did not express CD34, which is similar to other reports for canine 
MSCs [36‐38]. 





In contrast to CSCs, adMSC did not express Pax6,  which  was  not  expected  given  their origin. 
However, adMSC did express α‐SMA which was not detected at the protein level in 
undifferentiated CSCs. Α‐SMA expression has been reported in  human,  rat  and  murine MSCs 
previously [59‐61]. 
Alpha‐SMA, the earliest known protein expressed in differentiation of the smooth muscle 
cells during development and is also transiently expressed by a variety of mesodermal cells 
during development, tissue repair, and neoplastic growth [61]. Tissue repair and tumor 
microenvironment can convert MSCs into contractile myofibroblasts (MF) that form α‐ SMA‐
containing stress fibers [62,63]. MF activation is part of the wound healing response, but 
persistent MFs contribute to  fibrosis by excessively producing and contracting collagenous 
extracellular matrix (ECM) into stiff scar tissue [63]. 
Human CSCs have been shown to not only fail to induce the proliferation of allogeneic 
PBMCs but actually suppress the proliferation of activated PBMCs in vitro [8]. We have 
demonstrated that canine CSCs also appear to be immune privileged in vitro as they fail to 
induce the proliferation of PBMCs isolated from different donors. We carried out these 
assays on three different lines of CSCs each using PBMCs from two different donors (with 
PBMCs isolated from both lymph nodes and commercial suppliers) and all replicates 
produced very  consistent results.  However, the cells  were not  typed for  dog leukocyte 
antigens (DLA) and therefore we cannot rule out the possibility that the cells were not 
true‐mismatches. Further work is also required to determine if the CSCs are are immune 
suppressive. 
Canine CSCs (limbal and central) were successfully differentiated into cells with stellate 
keratocyte typical morphology that expressed keratocyte markers Keratocan, Lumican and 
ALDH1A3 [15,64,65]. ALDH1A3 is expressed in the murine cornea and is also required for 
corneal maintenance [66,67]. Similar to human studies, we could demonstrate that the 
gene expression levels of stem cell markers were downregulated and keratocyte markers 
were upregulated after 21 days of differentiation [12,68]. 
Canine CSCs continued to proliferate during the keratocyte differentiation process which 
might be driven by bFGF [69]. Therefore, KDM without bFGF was tested which led to stable 
cell   numbers   during   differentiation.   Although   the   absence   of   bFGF   during   the 





differentiation had no influence on keratocyte marker expression, it did lead to a 
significant increase in α‐SMA gene expression and the induction of detectable levels of 
protein. BFGF has been shown to downregulate α‐SMA expression in adMSCs previously 
[70]. In the injured cornea, keratocytes differentiate into myofibroblasts in response to 
TGFβ1 [71]. To date, the reverse process turning myofibroblasts into keratocytes has not 
been described [72]. From a translational medicine perspective, using α‐SMA expressing 
cells in vivo should be further investigated carefully. 
In conclusion, the limbus of dogs lacks limbal crypts as in humans but has an undulating 
basement membrane with CD90+ stromal cells in close proximity to the limbal epithelium. 
For the first time we characterize a cell population in the canine corneal stroma (limbal 
and central) that contains MSC‐like cells similar to CSSCs in humans with keratocyte 
differentiation potential and possible immune privilege properties. This novel finding of 
corneal stromal cells with multipotent mesenchymal stromal cell properties will provide a 
baseline for researchers working with canine corneal disease models and for cell‐based 
therapy in veterinary ophthalmology. 
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Figure 1 Histological and immunohistochemical staining of the canine limbal and central 
cornea with H&E and CD90. (A) an anatomical overview of the sclera, limbal (indicate 
by dashed lines) and central cornea (H&E stain); (B) the limbal cornea demonstrates 
an irregular, thickened and undulated basement membrane (arrow head, H&E) with 
close proximity of stromal cells (black arrow). (C) In the central cornea a fine regularly 
formed basement membrane is present (arrow head, H&E) and the keratocyte are 
more distant from the basement membrane (black arrow, H&E). (B) A distinct 
population of CD90 + expressing stromal cells were present in the limbal (CD90) and 
central anterior‐mid stroma (CD90). Nuclei are shown by DAPI counter staining and 
the cytoskeleton by Phalloidin. Scale bars: 500µm (A) 20µm (B, C); Abbreviations: ep, 
epithelium; st, stroma. 







Figure 2 Cell morphology and culture kinetics of limbal versus central corneal stromal cells 
(CSC). (Ai) Phase contrast images demonstrate the adherent, small, ovoid morphology 
of CSC. (Aii) The cell morphology changes to a more elongated, stellate shape 
intermixed with small ovoid cells up to 60‐70% confluency. (Aiii) With increasing 
confluency, a syncytium of stellate, elongated cells were formed. (B): Maximal number 
(mean ± SD) of cell passages in number of days (mean ± SD) and (C) cell counts over 
6 passages (mean ± SD) showed no significant difference between limbal and central 
CSC. (D): The population doubling time (h) and (E) cumulative number of cell doublings 
showed exponential growth over 5 passages and then reached senescence. There was 
no significant difference between central and limbal CSCs. Scale bar: 20µm; 
Abbreviations: h, hours; n, number of biological replicates; P, passages. 







Figure 3 Immunocytochemical profile of CSC in comparison to canine adipose derived 
mesenchymal stromal cells (adMSC): CSC and adMSC expressed CD73, CD90, CD105 
but not CD34; only CSC expressed Pax6 and only adMSC expressed α‐SMA. Limbal 
and central CSCs showed the same staining profile. Nuclei are shown by DAPI counter 
staining and the cytoskeleton by Phalloidin (Phall). Scale bar: 20µm; magnification: 
CSC (63x), adMSC (20x) 







Figure 4 Quantification of MSC markers and Pax6 in limbal CSCs by flow cytometry. Cell 
quantification demonstrated in dot plots (FITC‐H/FSC‐H) and histograms of 
normalized cell counts (%) of positive gated limbal CSC (red) with an overlap 
allowance of 2% to the IgG isotype (blue). 96.66% of limbal CSC were CD73+, 96.44% 
CD90+, 83.06% Pax+ and 1.39% CD34+. (% in mean, n=3). Abbreviations: FSC‐H, forward 
scatter height; FITC‐H, Fluorescein isothiocyanate height; n, number of biological 
replicates. 







Figure 5 Trilineage differentiation of limbal/central CSC, adMSC (A): Osteogenic 
differentiation of CSC (A i, iii, v) and adMSC (A ii, iv, vi) was confirmed via von Kossa 
(A i, ii), Alizarin S red (A iii, iv) and inorganic hydroxyapatite stain (Lonza®) (A v, vi) . 
Adipocyte differentiation of CSC (A vii) and adMSC (A viii) was confirmed with oil red 
O stain. (B): Chondrogenic differentiation of CSC (B i) in pellet form (see black arrow, 
photography of falcon tube inserted) and adMSC (B ii) and in higher magnification (B 
iii, iv) showed blue stained glycosaminoglycans deposits using Alcian blue stain 
between red counterstained stained cells. CSCs (B vi) and adMSC (B vii) showed 
chondrogenic differentiation in 2D (cell culture dish photography inserted) forming 
Alcian blue stained nodular formation (highlighted in magnified image boxes). There 
was no difference between limbal and central CSCs. Scale bar: 20 µm, B i,ii: 500 µm 







Figure 6 The PBMC co‐culture assay showed that allogeneic limbal CSC co‐cultured with 
PBMCs (red bar) did not modify the baseline level of non‐activated  PBMC proliferation 
(NA). In comparison co‐cultures of effector PBMCs with allogenic PBMCs showed a 
significant increase in proliferation compared to non‐activated PBMC (P< 0.01). The 
values represents the mean average proliferation ratio (±SE) to non‐ activated PBMC 
highlighted with a dashed line; n=3,*,p<0.05. Abbreviations: CSC, corneal stromal cells; 
NA, non‐activated; PBMC, peripheral blood mononuclear cells; PHA, 
Phytohemagglutinin; n, number of biological replicates. 







Figure 7 Limbal corneal stromal cells (CSC) differentiation into keratocyte‐like cells (KDC) in 
vitro. (A): Phase contrast images of CSC (Ai) demonstrated the increased cell size, 
stellate and elongated cell morphology of KDC (Aii) highlighted by the black arrows. 
(B): Images and table summarized the immunocytochemistry staining results. 
Keratocyte markers Lumican, Keratocan and ALDH1A3 in KDC were more strongly 
expressed than in CSC, the nuclear stem cell marker Pax6 was weaker and N‐cadherin 
was not expressed. Nuclei are shown by DAPI counter staining and the cytoskeleton 
by Phalloidin (Phall). Scale bar: 20µm; magnification: CSC (40x), KDC (63x). 







Figure 8 Limbal corneal stromal cells (CSC) differentiation into keratocyte‐like cells (KDC) in 
vitro. (A): Fold changes of quantitative reverse transcriptase polymerase chain 
reaction expression data showed the upregulation of Lumican, Keratocan (P< 0.05), 
ALDH1A3 and down regulation of Pax6, N‐cadherin (P<0.001). Α‐SMA was up 
regulated. Values represent mean ± SE, n=3,*, p<0.05. Abbreviations: n, number of 
biological replicates. (B): Immunocytochemical marker expression of α‐SMA (red) of 
CSC versus KDC. KDC cultured with bFGF did not express α‐SMA but in the absence of 
bFGF (– bFGF) α‐SMA was expressed. Nuclei are shown by DAPI counter staining and 
the cytoskeleton by Phalloidin (Phall). Scale bar: 20µm; magnification: CSC (40x), KDC 
(63x). (C): Quantitative reverse transcriptase polymerase chain reaction relative gene 
expression data of α‐SMA in KDC cultured without (‐bFGF) showed  significant  (P< 0.001) 
upregulation compared to CSC and KDC cultured with bFGF (+bFGF). Skin fibroblast 
cultured with substituted TGFß to induce up regulation of α‐SMA served as positive 
control. Values represent mean ± SE, n=3,*, p< 0.05. Abbreviations: bFGF, basic 
human fibroblast growth factor; TGFß, transforming growth factor beta. 





Supplementary Table S1. Donor details 
Case# Age (years) Sex Breed Tissue 
1 1.3 m Staffordshire bull terrier Cornea Os/Od 
2 1.2 m Staffordshire bull terrier Cornea Os/Od 
3 1.5 m Staffordshire bull terrier Cornea Os/Od 
4 1.8 m Staffordshire bull terrier Cornea Os/Od 
5 2 fs Cross breed Cornea Os/Od 
6 1 m Staffordshire bull‐cross breed Cornea Os/Od 
7 6 weeks m Dalmatian Cornea Os 
8 6weeks m Dalmatian Cornea Od 
9 8weeks f Old english sheepdog Cornea Os/Od 
10 8 mn Springer spaniel Cornea Os/Od 
11 12 mn Lurcher Cornea Os/Od 
12 12 mn Golden retriever Cornea Os/Od 
13 2 fs Border collie Cornea Os/Od 
14 8 fs Labrador Cornea Os/Od 
15 11 mn Mix Subcutaneous fat (adMSC) 
16 8 mn Irish setter Subcutaneous fat (adMSC) 
17 6 weeks m Dalmatian Subcutaneous fat (adMSC) 
18 8weeks f Bull terrier Popliteii lymph nodes 


























The table summarizes the donor details of dogs including age (years/weeks), sex, 
breed and tissue donated. Abbreviations: adMSC, adipose derived mesenchymal 
stromal cell; PBMC, peripheral blood mononuclear cells; f, female; fs, female‐ spayed; 
m, male; mn, male‐neutered; od, ocular dexter; os, ocular sinister 





Supplementary Table S2: Antibodies used for Immunfluorescence Staining (IF), Western 















(901301, Clone: Poly 19013, San 
Diego, CA, USA 
1:500 for IF 
 

















Abcam (ab129815, Cambridge, 
UK) 
 
1:500 for IF 
1:500 for WB 
56 
(unspecific 








Abcam (ab81289, Cambridge, 
UK) 
1: 100 for IF 
 
1:1000 for WB 
 











Bioss (bs‐4834R, Woburn, MA, 
USA) 
1:300 for IF 
 




Isoform 1: 63 
 
Isoform 2: 58 
 
CD90 
R&D systems  (AF 2067, 
Minneapolis, MN) 
1:100 for IF 
1:500 for WB 
 
23‐30 




















1:200 for IF 
 






Abcam (ab18203, Cambridge, 
UK) 
1:100 for IF 








1:100 for IF 
 
1:250 for WB 
50 
(unsp. band 141, 
41, 25kDa) 
Secondary and control 
antibody 
   
 
 
Anti Sheep IgG HRP 
 














1:200 for IF 
 
 
Anti‐Sheep IgG‐ NL493 
R&D systems  (Nl 012, 
Minneapolis, MN) 
 
1:200 for FC 
 
 
Anti‐Rabbit IgG HRP 
Dako (Agilent Technologies, 
Santa Clara, CA, USA) 
 
1:1000 for WB 
 











Sigma (F1262, Gillingham,UK) 
 
 
1:100 for FC 
 
 
Alexa Fluor 594 goat 
anti‐rabbit 
 
Invitrogen ( A‐11037 Thermo 
Fisher, Paisley, UK 
 
 
1:500 for IF 
 
 




Fisher, Paisley, UK) 
 
 




β‐actin loading control 
 
 























MG2a‐83, San Diego, CA, USA 
 
 




R&D systems  (5‐001‐A), 
Minneapolis, MN, USA) 
1:200 for IF 
 
2.5µg/106  cells 
 














2µg/106  cells 
for FC 
 
The table summarizes the antibodies used for Immunfluorescence Staining (IF), Western 
Blotting (WB), Flow Cytometry (FC) and information of the company details, catalogue 
number, dilution and molecular weight (MW) in kDA (kilo Dalton)/ band size. 
Reference 
1. Mai J, Q Hu, Y Xie, S Su, Q Qiu, W Yuan, Y Yang, E Song, Y Chen and J Wang. (2015). 
Dyssynchronous pacing triggers endothelial‐mesenchymal transition through 
heterogeneity of mechanical stretch in a canine model. Circ J 79:201‐9. 
 
2. Hensley MT, J Tang, K Woodruff, T Defrancesco, S Tou, CM Williams, M Breen, K Meurs, 
B Keene and K Cheng. (2017). Intracoronary allogeneic cardiosphere‐derived stem cells are 
safe for use in dogs with dilated cardiomyopathy. J Cell Mol Med 21:1503‐1512. 















Lumican AAACATTTGCGTCTGGATGG TATCAGGTGGCAGACTGGTG 55 
Keratocan TCATCTGCAGCACCTTCATC TGATTTCATTGCCATCCAGA 146 
ALDH1A3 GCCCTTTATCTGGGCTCTCT GACCCCGTGAAGGCTATCTT 137 
N‐cadherin TGTGAACGGGCAAATAACAA AGATCTGCAGCGTTCCTGTT 137 
Pax6 ATTACTGTCCGAGGGGGTCT CTAGCCAGGTTGCGAAGAAC 81 
Alpha‐SMA ACTGGGACGACATGGAAAAG CACGGAGCTCGTTGTAGAAA 54 
Canine 18S CCGCAGCTAGGAATAATGGA CCTCAGTTCCGAAAACCAAC 61 
The table summarizes the forward and reverse primer sequence used for real‐time PCR 
and the product size in base pair (bp). 
